manufacture natural gas compressors.

regis corporation (nyse:rgs), headquartered in minneapolis, minn., is a leader in beauty salons and cosmetology education. the company owns, franchises or holds ownership interests in nearly 10,000 worldwide locations. regis'​ corporate and franchise locations operate under concepts such as supercuts, smartstyle, mastercuts, regis salons, sassoon salon, cost cutters and first choice haircutters. regis maintains ownership interests in empire education group in the u.s. and the my style concepts in japan.

freshpet makes fresh and all natural refrigerated dog and cat food in the u.s., and is the fastest growing pet food brand, with refrigerators in over 16,000 stores. our mission is to bring the power of fresh food for pets everywhere in ways that are good for pets, people and the planet. at freshpet, we're passionate about what we do because we're pet lovers, and because we believe that as a team, we are making a real difference in pets'​ lives. while we’ve grown to a mid-sized company, it’s our entrepreneurial roots and small-company feel that make freshpet a thriving place to work.

HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases worldwide. It operates in two segments, Oncology/Immunology and Other Ventures. It manufactures, distributes, markets, and sells prescription and over-the-counter pharmaceutical, and consumer health products. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and clear cell renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors. It also develops Surufatinib, an inhibitor for neuroendocrine tumors (NET), pancreatic NET, non-pancreatic NET, biliary tract cancer, sarcoma, neuroendocrine neoplasm, esophageal cancer, small cell lung cancer, GC, thyroid cancer, EMC, NSCLC, and solid tumors; HMPL-523, an inhibitor for indolent non-Hodgkin's lymphoma (NHL), B-cell malignancies, and immune thrombocytopenic purpura; and HMPL-689 for indolent non-Hodgkin's, follicular, marginal zone, mantle cell, diffuse large B cell, chronic lymphocytic leukemia/small lymphocytic, and Hodgkin's lymphoma. The company develops HMPL-453, an inhibitor for intrahepatic cholangiocarcinoma; HMPL-306, an inhibitor for hematological malignancies, gliomas, and solid tumors; HMPL-295 for solid tumors; and HMPL-813 and HMPL-309 EGFR inhibitors. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, BeiGene, Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics (Suzhou) Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Central, Hong Kong.

lexington realty trust is a real estate investment trust that invests in, owns and manages commercial properties net leased to major corporations throughout the united states. in addition, the company provides investment advisory and asset management services to investors in the net lease area.

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Sterling Energy plc, together with its subsidiaries, operates as an upstream oil and gas company primarily in Africa and the Middle East. It is involved in the appraisal, exploration, development, and production of oil and gas. The company holds 34% interest in an exploration project covering approximately 22,840 square kilometers located in Somaliland. The company was incorporated in 1983 and is headquartered in London, the United Kingdom.

PureTech Health plc, a clinical stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and dementia-related psychosis; a hydrogel platform technology to treat obesity and other chronic metabolic diseases; a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions; a immunomodulation platform to treat chronic and acute inflammatory disorders; therapies for immune-mediated diseases based on a rationally-defined consortia of human microbiome-derived bacteria; and a digital treatments to treat cognitive dysfunction associated with neurology and psychiatry conditions. It also provides hematopoietic stem cell based therapies to treat hematological malignancies; a voice-based technology platform to measure health when a person speaks; and a technology platform for the oral delivery of biologics, vaccines, and other drugs. In addition, the company is developing LYT-100, an oral small molecule drug candidate to treat lymphedema, and other lymphatic flow disorders; LYT-200, a IgG4 monoclonal antibody to target galectin-9; LYT-210, a IgG1 monoclonal antibody; Glyph, a synthetic lymphatic targeting chemistry platform; milk exosome-based technology to enable the oral administration of macromolecule therapeutic payloads; and meningeal lymphatics platform to treat Alzheimer's and Parkinson's diseases. PureTech Health plc has collaboration and license agreements with Boehringer Ingelheim International GMBH; Roche Holding AG; Eli Lilly and Company; Imbrium Therapeutics L.P.; and Shionogi & Co., Ltd. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

kite realty group trust is a full-service, vertically-integrated real estate investment trust (reit) engaged primarily in the ownership and operation, acquisition, development and redevelopment of high-quality neighborhood and community shopping centers in select markets in the united states. as of june 30, 2016, the company owned interests in a portfolio of 121 operating, development and redevelopment properties totaling approximately 24 million total square feet across 20 states. our strategy is to maximize the cash flow of our operating properties, successfully complete the construction and lease-up of our development portfolio and identify additional growth opportunities in the form of acquisitions and redevelopments. new investments are focused in the shopping center sector in markets where we currently operate and where we believe we can leverage our existing infrastructure and relationships to generate attractive risk-adjusted returns.

applied optoelectronics, inc. | nasdaq: aaoi aoi is a leading designer and manufacturer of fiber optic networking products. we primarily serve three growing end-markets: cable television broadband, fiber-to-the-home, and internet data centers. we are vertically integrated with a product portfolio from laser chips, components, sub-assemblies and modules, to complete turn-key equipment. all three of our end-markets are driven by bandwidth demand fueled by the growth of network connected devices, such as video traffic, cloud computing and online social networking. to address this increased demand, catv and telecommunications service providers are investing to improve their networks in competition to deliver voice, video, and data services to their subscribers. rising bandwidth consumption is also driving demand for higher speed server connections in the internet data center market. as a result of these trends, fiber optic networking technology has become fundamental in all three of our ta